We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer.
- Authors
Kanda, Mitsuro; Shimizu, Dai; Sawaki, Koichi; Nakamura, Shunsuke; Umeda, Shinichi; Miwa, Takashi; Tanaka, Haruyoshi; Tanaka, Chie; Hayashi, Masamichi; Iguchi, Yohei; Yamada, Suguru; Katsuno, Masahisa; Kodera, Yasuhiro
- Abstract
Background: Controlling metastasis is essential for improving the prognosis of patients with gastric cancer (GC). Here, we aimed to identify a molecule required for GC metastasis and to investigate its potential utility as a target for the development of therapeutic antibodies (Abs). Methods: Transcriptome and bioinformatics analyses of human GC cell lines identified the neuronal pentraxin receptor (NPTXR) as a candidate molecule. NPTXR function was probed by modulating its expression in GC cells and assessing the effects on intracellular signaling and malignant behaviors in vitro and in mouse xenograft models. We also generated anti-NPTXR Abs and Nptxr−/− mice, and assessed the clinical significance of NPTXR expression in GC specimens. Results: NPTXR mRNA expression in clinical specimens was associated with disease progression and was significantly higher in tissues from GC patients with distant metastasis compared with those without. NPTXR regulated expression of genes involved in metastatic behaviors as well as activation of the PI3K–AKT–mTOR, FAK–JNK, and YAP signaling pathways. NPTXR silencing promoted caspase-mediated apoptosis and attenuated GC cell proliferation, cell cycle progression, migration, invasion, adhesion, stem cell-like properties, and resistance to 5-fluorouracil in vitro, and also inhibited the tumorigenicity of GC cells in vivo. Anti-NPTXR Abs inhibited GC peritoneal metastasis in mice. Nptxr−/− mice showed no abnormalities in reproduction, development, metabolism, or motor function. Conclusions: NPTXR plays an essential role in controlling the malignant behavior of GC cells in vitro and in vivo. NPTXR-targeting Abs may thus have utility as novel diagnostic tools and/or treatment modalities for GC.
- Subjects
STOMACH cancer; MONOCLONAL antibodies; PENTRAXINS; METASTASIS; CELL cycle; DISEASE progression; BLADDER cancer
- Publication
Molecular Cancer, 2020, Vol 19, Issue 1, pN.PAG
- ISSN
1476-4598
- Publication type
Article
- DOI
10.1186/s12943-020-01251-0